Publications by authors named "David Tickle"

Claim this Profile
C
Co-crystallisation and humanisation of an anti-HER2 single-domain antibody as a theranostic tool.
Kovilen Sawmynaden, Nicholas Wong, Sarah Davies, Richard Cowan, Richard Brown, David Tickle

PLoS One· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A "Target Class" Screen to Identify Activators of Two-Pore Domain Potassium (K2P) Channels.
David McCoull, Emma Ococks, Jonathan M Large, David C Tickle, Alistair Mathie

SLAS Discov· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Terbinafine is a novel and selective activator of the two-pore domain potassium channel TASK3.
Paul D Wright, Emma L Veale, David McCoull, David C Tickle, Jonathan M Large

Biochem Biophys Res Commun· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A High-Throughput Electrophysiology Assay Identifies Inhibitors of the Inwardly Rectifying Potassium Channel Kir7.1.
Paul D Wright, Srinivasan Kanumilli, David Tickle, Jamie Cartland, Nathalie Bouloc

J Biomol Screen· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The inwardly rectifying K+ channel KIR7.1 controls uterine excitability throughout pregnancy.
Conor McCloskey, Cara Rada, Elizabeth Bailey, Samantha McCavera, Hugo A van den Berg, David Tickle

EMBO Mol Med· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cloxyquin (5-chloroquinolin-8-ol) is an activator of the two-pore domain potassium channel TRESK.
Paul D Wright, Gregory Weir, Jamie Cartland, David Tickle, Catherine Kettleborough

Biochem Biophys Res Commun· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis